Sexual Differentiation and Substance Use: A Mini-Review

The organizational/activational hypothesis suggests that gonadal steroid hormones like testosterone (T) and estradiol (E2) are important at 2 different times during the lifespan when they perform 2 different functions. First steroids “organize” brain structures early in life and during puberty, and in adults these same hormones “activate” sexually dimorphic behaviors. This hypothesis has been tested and proven valid for a large number of behaviors (learning, memory, social, and sexual behaviors). Sex differences in drug addiction are well established both for humans and animal models. Previous research in this field has focused primarily on cocaine self-administration by rats. Traditionally, observed sex differences have been explained by the sex-specific concentrations of gonadal hormones present at the time of the drug-related behavior. Studies with gonadectomized rodents establishes an activational role for E2 that facilitates vulnerability in females, and when E2 is combined with progesterone, addiction is attenuated. Literature on organizational actions of steroids is sparse but predicts that T, after it is aromatized to E2, changes aspects of the neural reward system. Here we summarize these data and propose that sex chromosome complement also plays a role in determining sex-specific drug-taking behavior. Future research is needed to disentangle the effects of hormones and sex chromosome complement, and we propose the four core genotype mouse model as an effective tool for answering these questions.

Abstract WP325: X, but Not Y, Sex Chromosome Contributes to Stroke Sensitivity in Aged Mice

Introduction: Stroke is a sexually dimorphic disease. Women are protected against ischemia compared to men before menopause due to estrogen’s neuroprotection; after menopause the elderly women become vulnerable to stroke attack. Our previous studies with four core genotype mice found a chromosomal effect (either X or Y) in stroke sensitivity. Recently, we found two X-linked genes ( Kdm6a and Kdm5c ) that escape from X chromosome inactivation (XCI) are higher expressed in aged female vs. male microglia after stroke. KDM6A and KDM5C are histone demethylases that modify gene expression of inflammatory mediators. By these early studies, we hypothesized that the second X chromosome contributes to stroke sensitivity in aged mice through immune responses mediated by KDM6A and KDM5C. Methods: XY* aged (18-22 months) mice (natural menopause cohort) that have four genotypes (XO, XX, XY, XXY) were subjected to middle cerebral artery occlusion (MCAO). Another cohort of gonadectomized XY* mice were also used as the “surgical menopause” cohort. Infarct volumes and behavior deficits were quantified 3 days after MCAO. KDM6A and KDM5C localization with microglial marker TMEM119 was examined by IHC. Plasma inflammatory cytokine (IL-1β, TNF-α, IL-6, IL-4, TL-10, etc.) levels were analyzed with MultiPlex. The contribution of the second X-chromosome to stroke sensitivity was determined by comparing XX vs. XO or XXY vs. XY mice, and the effect of the Y-chromosome was evaluated by a comparison between XY vs. XO and XXY vs. XX mice. Results: In both surgical and natural menopause cohorts, XX and XXY mice showed worse stroke outcomes compared to XO or XY mice respectively; however, no significant difference was found between XX vs. XXY or XO vs. XY mice. IHC results showed higher expression of KDM6A and KDM5C in TMEM119 positive cells in mice with two vs. one copy of X chromosome. XXY mice had significantly higher levels of circulating TNF-α and IL-6 than XY mice. Conclusion: The second X chromosome contributes to stroke sensitivity in mice. Kdm6a and Kdm5c may play important roles in mediating post-stroke inflammation. Future work will genetically manipulate the expression of Kdm6a and Kdm5c in microglia to examine the roles of the two XCI escapee gene in stroke.